GW Department of Dermatology Receives Galderma Awards to Support ‘Sensitive Skin’ Research

The Department of Dermatology at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) recently received two awards from dermatology company Galderma to establish a research fund and a medical student research fellowship.

Dr. Adam Friedman smiling and wearing a blue shirt and red tie

“We are thrilled to partner with and receive this support from Galderma,” said Adam Friedman, MD, professor and chair of the Department of Dermatology at GW SMHS. “These funds allow us to expand our educational and care portfolios, and they build on our legacy of cutting-edge research.”

The first award will allocate $150,000 over five years to establish the Galderma Sensitive Skin Translational Research Fellowship Program. The program will support medical students interested in expanding their research skill set by preparing them to be contributing members of the investigative dermatology work force. It will also address an unmet need in dermatology: elucidating the underpinnings of sensitive skin to provide evidence-based approaches to management.

“Our goal is to define ‘sensitive skin’ as a distinct disease state, separate from being a symptom of a plethora of inflammatory skin diseases,” explained Friedman. “This program will help us not only address the current workforce gap but also improve training through a comprehensive curriculum of core requirements, elective courses, and didactic sessions to supplement fellows’ specialized training and individual research experiences.”

With the second award, $50,000 spread over two years, the Department of Dermatology will create the Galderma Sensitive Skin Research Acceleration Fund at GW. According to Friedman, there is no standard definition of “sensitive skin,” and this ambiguity can cloud provider and patient understanding.

“With GW as a hub for cutting-edge research, expert clinicians, complex skin conditions, and diverse patients, untangling ‘sensitive skin’ with evidence-based methods is an attainable goal,” Friedman said. “Our work will benefit patients and clinicians alike, and we are honored to have this opportunity.”

Latest News

Julie E. Bauman, MD, led a panel of leading cancer researchers who explored the future of cancer treatment as part of the GW Medicine Bicentennial Lecture Series. The hour-long lecture, titled “Harnessing the Immune System Against Cancer — From Shots to Stem Cells,” delved into innovative therapies…
The George Washington University School of Medicine and Health Sciences Department of Dermatology, in collaboration with the Pennsylvania Avenue Baptist Church and the National Psoriasis Foundation (NPF), announced a renewed funding commitment of $350,000 from Johnson & Johnson in support of…
The Center for Faculty Excellence recently named six faculty members from the George Washington University School of Medicine and Health Sciences as the newest cohort of members to the Academy of Education Scholars.